A Compassionate Use (CU) Program of Odronextamab

ConditionsRelapsed or Refractory (R/R) Follicular Lymphoma (FL)Diffuse Large B-Cell Lymphoma (DLBCL)B-Cell Non-Hodgkin Lymphoma (NHL)High-Grade B-Cell Lymphoma (HGBCL)

Trial statusAvailable

Trial phaseNot listed

Trial typeExpanded Access

Biological sexAll

AgeNot listed

SponsorRegeneron Pharmaceuticals

About this trial

Provide compassionate use of odronextamab

Eligibility criteria

Qualifiers

None

Disqualifiers

None

Trial design

Treatments tested in this trial

Odronextamab

Treatment groups

No treatment groups listed

Locations

This trial has no locations

Sponsors and collaborators

Regeneron Pharmaceuticals

Lead sponsor

Source ClinicalTrials.gov